1. 2007
Dupont Data Book

2. DuPont Investor Relations
1007 Market Street Wilmington, DE 19898
(302) 774 4994 Fax: (302) 773 2631
www.dupont.com
Copyright© 2008 DuPont. All Rights Reserved.
The DuPont Oval Logo, DuPont™, The miracles
of science™ and all products denoted with ™
and ® are trademarks or registered trademarks of
DuPont or its affiliates.

3. DuPont Investor Relations
Contents
1 2007 Summary
2 2007 At a Glance
4 Corporate Financial Data
Corporate Highlights
Segment Information
Carl Lukach Karen Fletcher
Consolidated Income Statements
Vice President Director
Consolidated Balance Sheets (302) 774-0001 (302) 774-1125
Consolidated Statements of Cash Flows
Selected Additional Data
14 DuPont Core Values, Sustainability
and Six Sigma
15 Industries, Regions and Ingredients
16 DuPont Science & Technology Laurie Conslato Lisa Curran Pamela Schools
Manager Manager, Agriculture Investor Relations
(302) 774-6088 & Nutrition Coordinator
18 Business Segments
(302) 774-1109 (302) 774-9870
Agriculture & Nutrition
Coatings & Color Technologies
Electronic & Communication Technologies
Performance Materials DuPont DATA BOOK has been prepared to assist financial analysts, portfolio managers
and others in understanding and evaluating the company. This book presents graphics,
Safety & Protection
tabular and other statistical data about the consolidated company and its business
Pharmaceuticals segments. The information presented in this book is generally included in—or can be
calculated from—previously issued press releases and published company reports on
Forms 10K, 10Q and 8K. Dollars are in millions except per share or where otherwise
39 Major Global Sites and Principal Products indicated. Most notes to financial statements are not included. This information is only
a summary and should be read in conjunction with the company’s audited consolidated
40 Major U.S. Sites and Principal Products financial statements and “Management’s Discussion and Analysis,” which is located in
the 2007 Form 10K filed with the Securities and Exchange Commission.
Inside Back Cover Use of Non-GAAP Measures
As a supplement to DuPont’s financial results prepared in accordance with U.S.
Board of Directors and generally accepted accounting principles (GAAP), this data book presents non-GAAP
measures that exclude significant items. Non-GAAP measures include pretax operating
DuPont Operating Team
income (PTOI) and PTOI margin; earnings and earnings per share; return on invested
capital (ROIC); earnings before interest, taxes, and minority interests (EBIT), as defined
by the company; and earnings before interest, taxes, minority interests, depreciation
and amortization (EBITDA). Non-GAAP measures are not a substitute for GAAP
results. Significant items represent special charges or credits that are important to an
understanding of the company’s ongoing operations. The company uses non-GAAP
measures to evaluate and manage the company’s operations. The company believes
that a discussion of results excluding special items provides a useful analysis of
ongoing operations. The determination of significant items may not be comparable to
similarly titled measures used by other companies.
A reconciliation of non-GAAP measures to GAAP results is provided on the Web at
www.dupont.com. For complete details of significant items, see DuPont’s quarterly
earnings news releases.
DuPont DATA BOOK is available on the Web at www.dupont.com.
Main Office Number: (302) 774-4994 The DuPont Oval Logo, DuPont™, The miracles of science®, and all products denoted
with ™ or ® are trademarks or registered trademarks of E.I. du Pont de Nemours and
Fax: (302) 773-2631 Company or its affiliates.
Internet: www.dupont.com April 2008

4. 2007 Summary
Delivering EPS*
Higher Profitability NetSales
Net Sales
ROIC** EPS* ROIC**
Pretax Operating Income Margin1
and Capital Returns
ands) (dollars) (dollars in thousands)
(percentage) (dollars)
(percentage) (percentage)
(dollars in billions) (percentage)
$3.50 $30
20% $3.50
20% 20%
2007 was a strong year. We executed our
$3.00 $3.00
growth and productivity initiatives and delivered $25
15% 15% 15%
results that exceeded our targets. In summary:
$2.50 $2.50
$20
• et sales increased 7% with emerging market
N $2.00 $2.00
sales increasing 18%. $15
10% 10% 10%
$1.50 $1.50
• verage selling price increased in each
A
$10
$1.00 $1.00
quarter, representing the fourth consecutive 5% 5% 5%
year of pricing gains. $5
$.50 $.50
• ixed cost as a percent of sales declined
F
150 basis points versus the prior year,
2004 2005 2006 2007 2003 2004 2005 2006 2007 2003 2004 2005 2006 2007
2003 2004 2005 2006 2007 2003 2004 2005 2006 2007
2003 2004 2005 2006 2007 2003
representing the fourth successive year of
Interiors, which was divested Textiles & Interiors, which was divested
in 2004
cost productivity gains.
• retax operating income (PTOI) margin
P
Net Sales
Net Sales EPS*
EPS*
Earnings Per Share1 ROIC**
ROIC**
Return on Invested Capital1, 2
increased 100 basis points (bps) to 17 percent.
(dollars)
(dollars inin thousands)
(dollars thousands) (dollars)
(dollars) (percentage)
(percentage) (percentage)
(percentage)
(percentage)
• arnings per share decreased 5%. Excluding
E
$30
$30 $3.50
$3.50 20%
20% 20%
20%
significant items, EPS increased 14%.
$3.00
$3.00
• eturn on Invested Capital (ROIC) 1,2 improved
R $25
$25
15%
15% 15%
15%
90 bps to 16 percent. $2.50
$2.50
$20
$20
$2.00
$2.00
$15
$15 10%
10% 10%
10%
Initiatives to Enhance $1.50
$1.50
Shareholder Value
$10
$10
$1.00
$1.00
5%
5% 5%
5%
In November 2005, DuPont announced a plan to
$5
$5 $.50
$.50
enhance shareholder value over a three-year
period. Our entire team is intensely focused on
2003 2004 2005 2006 2007
2003 2004 2005 2006 2007 2003 2004 2005 2006 2007
2003 2004 2005 2006 2007 2003 2004 2005 2006 2007
2003 2004 2005 2006 2007 2003
2003
delivering the plan and it shows in our progress
Textiles & Interiors, which was divested
Textiles & Interiors, which was divested Excludes the effect of OCI
Before significant items 2
1
through 2007 (table2004 While we are on
right).
in 2004
in
track and in some areas ahead of plan, it is time
November 2005 Action Items 2007 Results
to look forward and raise the bar again.
In January 2008, DuPont outlined goals and Increase fixed cost productivity – Ahead of plan
– Fixed costs as percent of sales
objectives for 2008 through 2010 in a five point
down 150 bps
plan. The company sees potential for double
– $400 million program savings delivered
digit earnings growth driven by advances in
– Confirmed early completion in 1Q 2008
several strategic areas:
Improve return on capital – On track
• ew science for growing agriculture markets
N
– ROIC increased 90 bps to 16 percent
• rowing demand for Safety & Protection
G
Accelerate return on innovation – On track
• pringboard position in emerging markets
S
– Sales from new products
• xtend cost productivity gains
E accounted for 36 percent of total
company revenues
• ccelerate commercialization of Applied
A
– Pipeline advances
BioSciences pipelines
– Continued progress DuPont Applied
BioSceince™
Repurchase shares – Successful Completion
– Repurchased $1.7 billion to complete
the $5 billion program or about 12%
of the shares outstanding.
2007 DuPont Data Book 1

5. DuPont 2007 At a Glance
DuPont has long been at work to improve the margins in all platforms as well as to grow faster in high growth markets and
geographies. Never has the work paid off so clearly as in 2007. Margins, return on capital and EPS were all up despite fast changing
conditions. Specifically, raw material inflation outpaced expectations and North America auto and housing conditions deteriorated.
These circumstances were effectively managed while growth in Agriculture, Safety and Security and emerging markets was driven
by focused new product and application development and infrastructure investments.
DuPont Packaging announced the expan-
January March
sion of its DuPont™ Biomax® Strong family
The day after his State of the Union DuPont and Honeywell announced a
of polymer additives to include a U.S.
address, President George W. Bush global joint development agreement to
Food and Drug Administration (FDA) com-
toured the DuPont Experimental Station, accelerate the development and commer-
pliant grade for food contact applications.
the company’s global research and devel- cialization of next generation, low global
opment facility, with a specific focus on warming refrigerants for the automotive
DuPont commercialized a unique line
DuPont’s leading-edge biofuels R&D and air conditioning industry.
of anti-reflective film coatings to
commercialization efforts.
significantly improve the image contrast
DuPont Tate & Lyle Bio Products LLC
and color quality of Liquid Crystal
DuPont announced the introduction of announced it is partnering with Cryotech
Displays (LCDs).
a new generation of DuPont™ Fodel® Deicing Technology, a world leader in
deicing solutions, to introduce Susterra™
conductive pastes that provide the elec-
June
trical connections for millions of pixels propanediol, a new 100 percent renew-
on the front and back glass used on ably sourced product. DuPont Tate & Lyle Bio Products,
plasma display panels (PDPs). LLC, officially opened its $100 million
DuPont™ SentryGlas Plus® was promi-
Bio-PDO® facility – the world’s first to
nently featured on the new U-shaped
produce propanediol from corn sugar.
February Grand Canyon West Skywalk observation
Bio-PDO® is a versatile, biodegradable
DuPont Crop Protection reached an platform, an all-glass flooring suspended
and high-performance ingredient that can
agreement with Valent U.S.A. Corporation 4,000 feet above the Colorado River.
be used in cosmetics, liquid detergents
to access flumioxazin to create new
and industrial applications.
combination herbicide products for soy- April
beans marketed under the DuPont brand. DuPont announced it will invest $58 mil-
DuPont introduced DuPont™ Energain®,
This is another step in DuPont’s strategy lion in biofuel production assets at two
an innovative concept in thermal mass
to provide a wider range of solutions to facilities as part of a partnership with BP
that provides a long-term sustainable
meet farmers’ needs in conventional, and British Sugar. The investment marks
solution to reduce energy consumption
Roundup Ready®, and Optimum™ GAT™ the progress being made to meet the
and greenhouse gas emissions in public,
seed systems. growing demand for biobutanol.
commercial and residential buildings.
DuPont announced its first plant biotech- DuPont and Environmental Defense
DuPont received a prestigious 2007 PACE
nology research center outside the United issued a comprehensive framework to
award for the company’s development
States will be located at the new DuPont assist with the responsible development
and commercialization of EcoConcept, a
Knowledge Center in Hyderabad, India. and use of nanotechnology and to help
finishing system that allows automobile
inform global dialogue on its potential
manufacturers to eliminate completely an
risks. The framework is intended for
entire coat in the painting process.
use by companies, regulatory agencies,
May universities and others with an interest in
commercializing nanoscale materials.
DuPont introduced DuPont™ Cromax®
Pro and DuPont™ Imron® ZV HG, two
new water-based finishes with reduced
environmental impact.
2

6. Photos: (Left) DuPont-BP Biobutanol
Program. (Middle) DuPont™ Nomex®
in Electrical Worker Protection.
(Right) DuPont Agriculture focused
on increasing yields.
July September November
DuPont announced that it has completed DuPont announced a $500 million DuPont opened offices in Bulgaria and
regulatory submissions for its Optimum™ production expansion plan for its high Serbia as part of its growth strategy for
GAT™ trait in corn to the U.S. Food & Drug performance Kevlar® para-aramid brand emerging markets.
Administration and the U.S. Department of fiber to serve the global marketplace for
DuPont introduced QualiTrakSM, a new
Agriculture. industrial and military applications. The
measurement and reporting system
expansion will increase Kevlar® capacity
DuPont announced that it has signed a that helps increase ethanol production
by more than 25 percent by 2010 and
Space Act Agreement with the National for ethanol plants and corn growers.
represents the largest expansion since
Aeronautics and Space Administration QualitrakSM will help plants produce more
Kevlar® was introduced in 1965.
(NASA) to jointly develop urethane foam ethanol with the same amount of grain.
insulation reinforced with DuPont™ DuPont introduced Accelerated Yield
DuPont reviewed with Investors the
Kevlar® fiber for use in a variety of future Technology™, a breakthrough commercial
Applied BioSciences technology
spacecraft, including the new launch technology that increases soybean yields
platform. Products highlighted at the
vehicle being designed to replace the by as much as 12 percent per acre.
investor event included: Bio-PDO™,
space shuttle.
DuPont announced plans to collaborate Sorona® and Cerenol™ for a wide range
DuPont announced that it will lead a with Plantic Technologies Ltd. in the of markets; biobutanol, an advanced
$100 million U.S. government program development and sale of new, renewably biofuel; BioSurfaces and Omega-3, based
to advance solar cell module research. sourced corn starch-based biomaterials on proprietary DuPont fermentation
DuPont is focused on providing for food and other packaging uses. technology; and ActaMax™, a surgical
renewable energy technologies to the sealant for medical applications.
October
photovoltaic market by developing
DuPont introduced DuPont™ Protera™,
new materials that make solar cells December
a new line of inherently flame resistant
smaller and lighter, more efficient and DuPont announced a joint venture with
fabrics specifically engineered to
cost effective. Beijing Weiming Kaituo Agriculture
protect against electric arc hazards Biotechnology Co., Ltd. (BWK) to acceler-
and meet NFPA 70E as well as the new
August ate the discovery of genes for high-value
National Electrical Safety Code (NESC)
DuPont acquired from Process Dynamics, agronomic traits such as stress toler-
requirements.
Inc., certain business assets including ance and efficient nutrient utilization to
its IsoTherming™ Technology and intel- improve the performance of important
DuPont’s BAX® system was selected by
lectual property. This leading technology crops for farmers in China and through-
the Beijing Municipal Center for Food
is used to dramatically reduce sulfur in out the world.
Safety Monitoring to supervise food
motor fuels. safety in 2008. The BAX® detection system DuPont Crop Protection received federal
will be used to provide technical support
DuPont signed an agreement with GC registration approval from the U.S.
food safety management for the athletic
Corporation of Tokyo, Japan, a major Environmental Protection Agency for
sports competition in 2008.
global manufacturer of dental materials DuPont™ Enlite™ and Envive™, two soy-
and equipment, to provide next-generation bean pre-emergence herbicides designed
dental monomer technology that reduces to provide growers with a better tool for
the shrinkage of dental composites. managing weed resistance.
2007 DuPont Data Book 3

7. Corporate Financial Data
Corporate Highlights
(dollars in millions, except per share)
2006
2007
Net sales $ 27,421
Operating Results $ 29,378
Income 1 3,148
2,988
Net income 3,148
2,988
Income before significant items 1 2,685
3,043
Depreciation 1,157
1,158
EBIT 3,667
4,113
EBITDA 5,020
5,450
Cash provided by operating activities 3,736
4,290
Capital expenditures 1,563
1,698
Research and development expense 4 1,302
1,338
Total assets $ 31,777 5
Financial Position, $ 34,131
Working capital 4,930
Year End 4,619
Total debt 7,530
7,325
Stockholders’ equity 9,422 5
11,136
Income 1, 7 $3.38
Data Per Common Share $3.22
Net income 7 $3.38
$3.22
Income before significant items 1, 7 $2.88
$3.28
Dividends $1.48
$1.52
Market price – Year-end close $48.71
$44.09
High-low range $49.68 – $38.52
$53.90 – $42.25
Book value at year-end $9.96
$12.12
Average number of shares (millions) – diluted 929
925
Shares outstanding – year-end (millions) 922
899
Total stockholder return 18.1%
Ratios (6.4)%
Dividend yield 3.0%
3.4%
Share price increase (decrease) 14.6%
(9.5)%
P/E on income before significant items 1, 8 17
13
Dividend payout, as percentage of earnings per share
before significant items 1 51.4%
46.3%
Return on average stockholders’ equity before significant items 1, 3 25.7%
25.6%
Return on average investors’ capital before significant items 1, 3 15.3%
16.2%
Asset turnover ratio 86%
86%
Cash provided by operating activities as a percentage of total debt 49.6%
58.6%
Debt to total capital 6 43.3%
38.8%
Interest coverage ratio 9 9.1
11.0
Current ratio 6 1.6
1.5
Exchange loss – net of tax $ (30)
$ (31)
Number of employees – year-end (thousands) 59
Employees 60
1 Before cumulative effect of changes in accounting principles. 6 Includes related assets and/or liabilities classified as held for sale within the
2 Includes a cumulative effect of a change in accounting principle charge of $29 and $0.03 Consolidated Balance Sheets.
per share (diluted). 7 Diluted, based on average number of common shares.
3 Amount presented ex-Other Comprehensive Income. 8 Based on year-end share price.
4 Excludes purchased in-process research and development. 9 Income before significant items and income taxes, plus the sum of interest expense
5 On December 31, 2006, the company adopted Statement of Financial Accounting and amortization of capitalized interest less interest income, divided by the sum of
Standards No. 158,“Employers’ Accounting for Defined Benefit Pension and Other interest expense and capitalized interest less interest income.
Postretirement Plans, an amendment of FASB Statements No. 87, 88, 106 and 132(R).”
Total assets and stockholders’ equity were reduced by $2,159 and $1,555, respectively,
as a result of such adoption.
4

8. 2005 2004 2003 Cash Provided By Cash Returned to Shareholders
Operating Activities
$ 26,639 $ 27,340 $ 26,996
2,056 (dollars) 1,780 1,002 (dollars in millions) (dollars in millions)
2,056 $3.00 1,780 973-2 $5,000
$4,500
2,332 2,393 1,669
$3,750
$2.50
1,128 1,124 1,355 $4,000
3,884 $2.00 1,687 407 $3,000
$3,000
5,209 3,000 1,938
$1.50 $2,250
2,542 3,231 2,589 $2,000
1,406 $1.00 1,298 1,784 $1,500
1,336 1,333 1,349 $1,000
$0.50 $750
$ 33,291 $ 35,632 $ 37,039
4,986 7,272 5,419
2002 2003 2004 2005 2006 2003 2004 2005 2006 2007 2003 2004 2005 2006 2007
8,180 6,485-6 10,479-6
8,962 11,377 9,781 Dividends
Share Repurchase
$2.07 $1.77 $0.99
$2.07 $1.77 $0.96-2 2003-2007 Cash Waterfall
$2.34 $2.38 $1.66
$1.46 $1.40 $1.40 (dollars in billions)
$25
$42.50 $49.05 $45.89
$54.90 – $37.60 $49.39 – $39.88 $46.00 – $34.71
$20
$9.49 $11.20 $9.57
989 1,003 1,000
920 994 997 $15
(10.4)% 9.9% 11.5%
3.4% 2.9% 3.1%
$10
(13.4)% 6.9% 8.2%
18 21 28
$5
62.4% 58.8% 84.3%
19.6% 20.2% 14.1%
$0
12.4% 11.5% 8%
Cash Cash from Asset PPE & Dividends Stock Chg. in Debt/ Cash
80% 77% 73% 12/31/02 Operating Sales Affil. Invest. Repurchase All Other 12/31/07
Activities
31.1% 49.8% 24.7%
46.4% 34.2% 50.3%
Five-Year Performance 2003–2007
11.1 11.5 7.9
1.7 1.9 1.2
Stockholder Return DuPont S&P 500
$ (38) $ (51) $ (3)
Dividend Yield1 3.17% 1.74%
60 60 81
Share Price Annual Appreciation -1.00% 7.20%
2
Total Annual Return 4.16% 12.81%
2, 3
Dividend Growth 2.08% 14.16%
2
Ten-Year Performance 1998–2007
Stockholder Return DuPont S&P 500
Dividend Yield1 3.00% 1.56%
Share Price Annual Appreciation2 -2.04% -0.01%
Total Annual Return2, 3 -0.08% 5.90%
Dividend Growth 1.20% 6.90%
2
1 Average annual dividend yield based on year-end stock price over the period shown.
2 Compound annual growth rate over the period shown.
3 Includes reinvestment of dividends.
2007 DuPont Data Book 5

9. Corporate Financial Data
Segment Information
(dollars in millions)
2006 2005
2007
Segment Sales 1
Agriculture & Nutrition $ 6,008 $ 6,090
$ 6,842
Coatings & Color Technologies 6,290 6,055
6,609
Electronic & Communication Technologies 3,573 3,408
3,797
Performance Materials 6,179 6,062
6,630
Safety & Protection 5,496 5,144
5,641
Other 180 174
178
Total segment sales 27,726 26,933
29,697
Elimination of transfers (305) (294)
(319)
Net sales $27,421 $26,639
$29,378
Segment Pretax Operating Income – Before Significant Items
Agriculture & Nutrition $ 725 $ 875
$ 894
Coatings & Color Technologies 827 649
840
Electronic & Communication Technologies 572 510
594
Performance Materials 636 523
811
Pharmaceuticals 819 751
949
Safety & Protection 1,107 1,016
1,199
Other (173) (129)
(184)
Total segment pretax operating income – before significant items 4,513 4,195
5,103
Exchange gains (losses) (4) 445
(85)
Corporate expenses & interest (1,047) (1,049)
(1,056)
Income before significant items, income taxes and minority interests 3,462 3,591
3,962
Net significant items 2 (133) (28)
(219)
Income before income taxes and minority interests $ 3,329 $ 3,619
$ 3,743
1 Segment sales include transfers.
2 For complete details of significant items, see DuPont’s quarterly earnings news releases.
DuPont’s Share of After Tax
Equity Affiliate Earnings
2006 2005
2007
Equity Affiliate Analysis
Agriculture & Nutrition $ (3) $ (3)
$ 3
Coatings & Color Technologies 0 1
1
Electronic & Communication Technologies 48 39
36
Performance Materials 10 26
(155)
Safety & Protection 20 18
22
Other (8) 11
(14)
Total segments $ 67 $ 92
$ (107)
6

10. 2006
2007
1st 2nd 3rd 4th Full Yr.
1st 2nd 3rd 4th Full Yr.
Segment Sales 1
Agriculture & Nutrition $ 2,174 $1,935 $ 885 $1,014 $ 6,008
$ 2,450 $2,074 $1,067 $1,251 $ 6,842
Coatings & Color Technologies 1,478 1,625 1,612 1,575 6,290
1,559 1,701 1,649 1,700 6,609
Electronic & Communication Technologies 920 885 942 892 854 3,573
979 935 963 3,797
Performance Materials 1,541 1,556 1,559 1,523 6,179
1,589 1,679 1,651 1,711 6,630
Safety & Protection 1,360 1,413 1,385 1,338 5,496
1,370 1,466 1,408 1,397 5,641
Other 46 48 47 39 180
43 50 43 42 178
Total segment sales $ 7,484 $7,519 $6,380 $6,343 $27,726
$ 7,931 $7,949 $6,753 $7,064 $29,697
Segment Pretax Operating Income –
Before Significant Items
Agriculture & Nutrition $ 597 $ 430 $ (154) $ (148) $ 725
$ 651 $ 428 $ (96) $ (89) $ 894
Coatings & Color Technologies 156 228 238 205 827
194 226 204 216 840
Electronic & Communication Technologies 160 168 132 112 572
124 176 138 156 594
Performance Materials 155 191 169 121 636
202 227 196 186 811
Pharmaceuticals 169 200 210 240 819
225 241 237 246 949
Safety & Protection 268 308 286 245 1,107
291 318 313 277 1,199
Other (56) (32) (31) (54) (173)
(56) (37) (36) (55) (184)
Total segment pretax operating
income – before significant items 1,631 1,449 1,493 850 721 4,513
1,579 956 937 5,103
Exchange gains and losses (18) 26 (3) (9) (4)
(28) 8 (30) (35) (85)
Corporate expenses and interest (253) (264) (261) (269) (1,047)
(239) (279) (256) (282) (1,056)
Income before significant items 2 1,178 1,255 586 443 3,462
1,364 1,308 670 620 3,962
Pretax Impact of Significant Items 2
Impairment charge – – – – –
– – – (165) (165)
Litigation related items – – – – –
(52) – (40) 32 (60)
Restructuring activities (135) – – (194) (329)
– – – – –
Hurricane insurance proceeds – – 50 93 143
– – – – –
Corporate tax-related items 7 – – 90 97
– – – 6 6
Asbestos insurance recoveries – – – 61 61
– – – – –
Sales terms and expense
accrual changes – – – (58) (58)
– – – – –
Impairment loss on asset held-for-sale – – – (47) (47)
– – – – –
Net impact of significant items (128) – 50 (55) (133)
(52) – (40) (127) (219)
Income before income taxes and
minority interests $ 1,050 $ 1,255 $ 636 $ 388 $ 3,329
$ 1,312 $ 1,308 $ 630 $ 493 $ 3,743
2006
2007
1st 2nd 3rd 4th Full Yr.
1st 2nd 3rd 4th Full Yr.
Earnings Per Share of
Common Stock – Diluted 3
Income before significant items $ 0.93 $ 1.01 $ 0.49 $ 0.45 $ 2.88
$ 1.07 $ 1.04 $ 0.59 $ 0.57 $ 3.28
Significant items (0.05) 0.03 0.03 0.49 0.50
(0.06) 0.00 (0.03) 0.03 (0.06)
Income (loss) $ 0.88 $ 1.04 $ 0.52 $ 0.94 $ 3.38
$ 1.01 $ 1.04 $ 0.56 $ 0.60 $ 3.22
1 Segment sales include transfers.
2 For complete details of significant items, see DuPont’s quarterly earnings news releases.
3 Earnings per share for the year does not equal to sum of quarterly earnings per share due to changes in average share calculations.
2007 DuPont Data Book 7

11. Corporate Financial Data
Consolidated Income Statements
(dollars in millions, except per share)
For the year ended December 31 2006 2005 2004 2003
2007
$27,421 $26,639 $27,340 $26,996
Net sales $29,378
Other income, net 1 1,561 1,852 655 734
1,275
Total 28,982 28,491 27,995 27,730
$30,653
Cost of goods sold and other operating charges 20,440 19,683 20,827 20,742
21,565
Selling, general and administrative expenses 3,224 3,223 3,141 3,067
3,364
Amortization of intangible assets 227 230 223 229
213
Research and development expense 1,302 1,336 1,333 1,349
1,338
Interest expense 460 518 362 347
430
Separation activities – Textiles & Interiors – (62) 667 1,620
–
Goodwill impairment – Textiles & Interiors – – – 295
–
Gain on sale of interest by subsidiary – nonoperating – – – (62)
–
Total 25,653 24,928 26,553 27,587
26,910
3,329 3,563 1,442 143
Income before income taxes and minority interests 3,743
Provision for (benefit from) income taxes 196 1,470 (329) (930)
748
Minority interests in earnings (losses) of
consolidated subsidiaries (15) 37 (9) 71
7
Income before cumulative effect of changes in
3,148 2,056 1,780 1,002
accounting principles 2,988
Cumulative effect of changes in accounting principles,
net of income taxes – – – (29)
–
$ 3,148 $ 2,056 $ 1,780 $ 973
Net income $ 2,988
Diluted earnings per share of common stock
Income before cumulative effect of
changes in accounting principles $ 3.38 $ 2.07 $ 1.77 $ 0.99
$ 3.22
Cumulative effect of changes in accounting principles – – – (0.03)
–
Net income $ 3.38 $ 2.07 $ 1.77 $ 0.96
$ 3.22
1 Other income, net:
$ 815 $ 747 $ 675 $ 573
$ 951
Cozaar®/Hyzaar® licensing income
120 130 151 141
125
Royalty income
129 227 191 129
154
Interest income
50 108 (39) 10
(130)
Equity in earnings (losses) of affiliates
78 82 28 17
126
Net gains on sales of assets
16 423 (391) (134)
(65)
Net exchange gains (losses)
353 135 40 (2)
114
Miscellaneous income and expenses – net
$ 1,561 $ 1,852 $ 655 $ 734
$ 1,275
Total Other income, net
8

12. Consolidated Balance Sheets
(dollars in millions)
December 31 2006 2005 2004 2003
2007
Assets
Current assets
Cash and cash equivalents $ 1,814 $ 1,736 $ 3,369 $ 3,273
$ 1,305
Marketable debt securities 79 115 167 25
131
Accounts and notes receivable, net 5,198 4,801 4,889 4,218
5,683
Inventories 4,941 4,743 4,489 4,107
5,278
Prepaid expenses 182 199 209 208
199
Income taxes 656 828 1,557 1,141
564
Assets held for sale – – 531 5,490
–
Total current assets 12,870 12,422 15,211 18,462
13,160
25,719 24,963 23,978 24,149
Property, plant and equipment 26,593
Less: Accumulated depreciation 15,221 14,654 13,754 14,257
15,733
Net property, plant and equipment 10,498 10,309 10,224 9,892
10,860
2,108 2,087 2,082 1,939
Goodwill 2,074
2,479 2,684 2,848 2,986
Other intangible assets 2,856
803 844 1,034 1,304
Investment in affiliates 818
3,019 4,945 4,233 2,456
Other assets 4,363
$31,7771 $33,291 $35,632 $37,039
Total $34,131
Liabilities and Stockholders Equity
Current liabilities
Accounts payable $ 2,711 $ 2,670 $ 2,661 $ 2,341
$ 3,172
Short-term borrowings and capital lease obligations 1,517 1,397 936 5,914
1,370
Income taxes 178 294 192 60
176
Other accrued liabilities 3,534 3,075 4,054 3,034
3,823
Liabilities held for sale – – 96 1,694
–
Total current liabilities 7,940 7,436 7,939 13,043
8,541
6,013 6,783 5,548 4,301
Long-term borrowings and capital lease obligations 5,955
7,692 8,441 8,692 8,909
Other liabilities 7,255
269 1,179 966 508
Deferred income taxes 802
Total liabilities 21,914 23,839 23,145 26,761
22,553
441 490 1,110 497
Minority interests 442
9,4221 8,962 11,377 9,781
Stockholders’ equity 11,136
$31,777 $33,291 $35,632 $37,039
Total $34,131
1 On December 31, 2006, the company adopted Statement of Financial Accounting Standards No. 158, “Employers’ Accounting for Defined Benefit Pension and Other Postretirement Plans,
an amendment of FASB Statements No. 87, 88, 106 and 132(R).” Total assets and stockholders’ equity were reduced by $2,159 and $1,555, respectively, as a result of such adoption.
2007 DuPont Data Book 9